Salesforce Stock Price May Be Underestimating Business Value

Salesforce (CRM) has seen its stock price decline by 22.6% year to date, but recent market checks and intrinsic value estimates suggest the shares may be undervalued.

The company's recent AI-related developments, such as Agentforce 360's U.S. Department of Defense authorization, could support long-term cash flow expectations.

However, customer decisions like Curative replacing Salesforce with an in-house CRM highlight the risk that buyers may reassess large software contracts.

A Discounted Cash Flow (DCF) intrinsic value estimate puts Salesforce' shares at about 47.8% above the market price, indicating that the stock is undervalued in most checks.